BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 11702089)

  • 1. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
    Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats.
    Terner JM; Barrett AC; Grossell E; Picker MJ
    Psychopharmacology (Berl); 2002 Sep; 163(2):183-93. PubMed ID: 12202965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor.
    Morgan D; Cook CD; Picker MJ
    J Pharmacol Exp Ther; 1999 May; 289(2):965-75. PubMed ID: 10215676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exercise decreases sensitivity to mu opioids in female rats: correlation with exercise output.
    Smith MA; Lyle MA
    Pharmacol Biochem Behav; 2006 Sep; 85(1):12-22. PubMed ID: 16904173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
    Walker EA; Young AM
    Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
    Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
    Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
    Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.
    Peckham EM; Traynor JR
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in opioid antinociception.
    Bartok RE; Craft RM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):769-78. PubMed ID: 9262340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
    Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
    Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
    Allen RM; Granger AL; Dykstra LA
    J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
    Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor.
    Smith MA; Gray JD
    Psychopharmacology (Berl); 2001 Aug; 156(4):445-53. PubMed ID: 11498722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.